METHOD FOR TREATING MULTIPLE SCLEROSIS (VERSIONS) Russian patent published in 2020 - IPC A61K38/27 A61K38/30 A61P25/28 

Abstract RU 2721282 C2

FIELD: medicine; neurology.

SUBSTANCE: invention refers to treating multiple sclerosis. That is ensured by administering somatotropin in amount of 0.05 to 0.5 IU/kg of body weight, or insulin-like growth factor 1 (IGF-1) in amount of 50 to 500 mcg/kg of body weight, or their physiological inducers.

EFFECT: this provides effective reduction of the disease symptoms with no side effects.

4 cl, 2 tbl, 2 ex

Similar patents RU2721282C2

Title Year Author Number
HYBRID PROTEIN IGF-1-LONG FOR TREATING STROKE, NUCLEIC ACID, VECTOR, CELL, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT 2018
  • Dukhovlinov Ilya Vladimirovich
RU2711111C1
NEW METHODS FOR TREATING MULTIPLE SCLEROSIS 2018
  • Shimshek, Derya
RU2765820C2
METHOD FOR TREATING MULTIPLE SCLEROSIS USING LSD1 INHIBITOR 2017
  • Maes, Tamara
  • Mascaro Crusat, Cristina
  • Rotllant Pozo, David
RU2768120C2
TREATMENT OF DEMYELINATING DISEASES 2019
  • Kivell, Bronvin Mari
  • La Flamme, Anna Kamilla
  • Prisintsano, Tomas Edvard
RU2805061C2
COMPOSITION AND METHOD OF AUTOIMMUNE DISEASES TREATMENT 2012
  • Fatkhi Reza
  • Maklin Patrik Laflin
  • Lejton Garri Dzhefferson
RU2621129C2
APPLICATION OF 5'-METHYLTHIOADENOSINE (MTA) FOR PREVENTION AND/OR TREATMENT OF AUTOIMMUNE DISEASES AND/OR GRAFT REJECTION 2005
  • Vil'Oslada Dias Pablo
  • Avila Saragosa Matias
  • Moreno Bruna Beatris
  • Korrales Isk'Erdo Fernando
  • Berasajn Lasarte Karmen
  • Ruis Garsia-Trevikhano Ehlena
RU2393866C2
ANALGETIC AGENT ON THE BASIS OF PLASMID DNA CODING HNP-1, OR HNP-2, OR HNP-3 (VERSIONS) 2014
  • Dukhovlinov Ilya Vladimirovich
  • Orlov Anton Iosifovich
RU2597789C2
APPLICATION OF 4-AMINOPYRIDINE FOR IMPROVING CONDITION IN CASE OF NEUROCOGNITIVE AND/OR NEUROPSYCHIATRIC DISORDER IN PATIENTS WITH DEMYELINATING AND OTHER DISEASES OF NERVOUS SYSTEM 2010
  • Vessel' Tomas K.
  • Blajt Ehndrju
RU2563821C2
PHARMACEUTICAL COMPOSITION FOR GENETIC THERAPY OF DISEASES REQUIRING STIMULATION OF REGENERATIVE PROCESSES, INCLUDING HUMAN TISSUE DAMAGES OF VARIOUS AETIOLOGIES, BASED ON SYNTHETIC MODIFIED GENE OF INSULIN-LIKE HUMAN GROWTH FACTOR TYPE ONE (IFR-1, IGF-1) 2007
  • Ivanov Igor' Al'Bertovich
RU2372941C2
SOBETIROME DERIVATIVES 2017
  • Scanlan, Thomas
  • Devereaux, Jordan
  • Placzek, Andrew
  • Banerji, Tapasree
  • Ferrara, Skylar
  • Meinig, James Matthew
  • Banerji, Tania
RU2776372C2

RU 2 721 282 C2

Authors

Dukhovlinov Ilya Vladimirovich

Dates

2020-05-18Published

2017-11-21Filed